# Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

> **NCT01404182** · PHASE4 · COMPLETED · sponsor: **Fluart Innovative Vaccine Ltd, Hungary** · enrollment: 121 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Vaccination with Fluval AB influenza vaccine

## Key facts

- **NCT ID:** NCT01404182
- **Lead sponsor:** Fluart Innovative Vaccine Ltd, Hungary
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404182, "Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01404182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*